These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 17952078)

  • 1. NKG2D signaling is coupled to the interleukin 15 receptor signaling pathway.
    Horng T; Bezbradica JS; Medzhitov R
    Nat Immunol; 2007 Dec; 8(12):1345-52. PubMed ID: 17952078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural killer cell signaling pathways.
    Vivier E; Nunès JA; Vély F
    Science; 2004 Nov; 306(5701):1517-9. PubMed ID: 15567854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors.
    André P; Castriconi R; Espéli M; Anfossi N; Juarez T; Hue S; Conway H; Romagné F; Dondero A; Nanni M; Caillat-Zucman S; Raulet DH; Bottino C; Vivier E; Moretta A; Paul P
    Eur J Immunol; 2004 Apr; 34(4):961-71. PubMed ID: 15048706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer cell receptor signaling pathway.
    Vély F; Vivier E
    Sci STKE; 2005 Jul; 2005(292):cm6. PubMed ID: 16014603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The NKG2D receptor: sensing stressed cells.
    López-Larrea C; Suárez-Alvarez B; López-Soto A; López-Vázquez A; Gonzalez S
    Trends Mol Med; 2008 Apr; 14(4):179-89. PubMed ID: 18353724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of silencing NKG2D through RNA interference on receptor functions in interleukin-2-activated human natural killer cells.
    Baeriswyl V; Wodnar-Filipowicz A; Kalberer CP
    Haematologica; 2006 Nov; 91(11):1538-41. PubMed ID: 17043026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NKG2D-mediated activation of cytotoxic lymphocytes: unique signaling pathways and distinct functional outcomes.
    Upshaw JL; Leibson PJ
    Semin Immunol; 2006 Jun; 18(3):167-75. PubMed ID: 16723257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NKG2D ligands: key targets of the immune response.
    González S; López-Soto A; Suarez-Alvarez B; López-Vázquez A; López-Larrea C
    Trends Immunol; 2008 Aug; 29(8):397-403. PubMed ID: 18602338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NKG2D ligands in tumor immunity.
    Nausch N; Cerwenka A
    Oncogene; 2008 Oct; 27(45):5944-58. PubMed ID: 18836475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Versatile signaling through NKG2D.
    Long EO
    Nat Immunol; 2002 Dec; 3(12):1119-20. PubMed ID: 12447364
    [No Abstract]   [Full Text] [Related]  

  • 11. Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D.
    Diefenbach A; Tomasello E; Lucas M; Jamieson AM; Hsia JK; Vivier E; Raulet DH
    Nat Immunol; 2002 Dec; 3(12):1142-9. PubMed ID: 12426565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NKG2D and cytotoxic effector function in tumor immune surveillance.
    Hayakawa Y; Smyth MJ
    Semin Immunol; 2006 Jun; 18(3):176-85. PubMed ID: 16675266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NK cells and cancer immunosurveillance.
    Waldhauer I; Steinle A
    Oncogene; 2008 Oct; 27(45):5932-43. PubMed ID: 18836474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of NKG2D signaling prevents the development of murine CD4+ T cell-mediated colitis.
    Ito Y; Kanai T; Totsuka T; Okamoto R; Tsuchiya K; Nemoto Y; Yoshioka A; Tomita T; Nagaishi T; Sakamoto N; Sakanishi T; Okumura K; Yagita H; Watanabe M
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G199-207. PubMed ID: 17962357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer cell receptor signaling pathway in mammals.
    Vély F; Vivier E
    Sci STKE; 2005 Jul; 2005(292):cm7. PubMed ID: 16014604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the NKG2D receptor for tumor immunity.
    Coudert JD; Held W
    Semin Cancer Biol; 2006 Oct; 16(5):333-43. PubMed ID: 16914326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NKG2D function protects the host from tumor initiation.
    Smyth MJ; Swann J; Cretney E; Zerafa N; Yokoyama WM; Hayakawa Y
    J Exp Med; 2005 Sep; 202(5):583-8. PubMed ID: 16129707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathways participating in activation of mouse uterine natural killer cells during pregnancy.
    Xie X; He H; Colonna M; Seya T; Takai T; Croy BA
    Biol Reprod; 2005 Sep; 73(3):510-8. PubMed ID: 15878887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NKG2D-mediated signaling requires a DAP10-bound Grb2-Vav1 intermediate and phosphatidylinositol-3-kinase in human natural killer cells.
    Upshaw JL; Arneson LN; Schoon RA; Dick CJ; Billadeau DD; Leibson PJ
    Nat Immunol; 2006 May; 7(5):524-32. PubMed ID: 16582911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of NKG2D ligands and subsequent enhancement of NK cell-mediated lysis of cancer cells by arsenic trioxide.
    Kim JY; Bae JH; Lee SH; Lee EY; Chung BS; Kim SH; Kang CD
    J Immunother; 2008 Jun; 31(5):475-86. PubMed ID: 18463537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.